nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.124	0.248	CbGbCtD
Fulvestrant—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0938	0.188	CbGbCtD
Fulvestrant—CYP3A4—Betamethasone—ankylosing spondylitis	0.0804	0.161	CbGbCtD
Fulvestrant—CYP3A4—Prednisolone—ankylosing spondylitis	0.0794	0.159	CbGbCtD
Fulvestrant—CYP3A4—Prednisone—ankylosing spondylitis	0.075	0.15	CbGbCtD
Fulvestrant—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0468	0.0937	CbGbCtD
Fulvestrant—Embolism venous—Betamethasone—ankylosing spondylitis	0.00994	0.0199	CcSEcCtD
Fulvestrant—Embolism venous—Prednisone—ankylosing spondylitis	0.00866	0.0173	CcSEcCtD
Fulvestrant—Cough increased—Triamcinolone—ankylosing spondylitis	0.00604	0.0121	CcSEcCtD
Fulvestrant—Vaginal discharge—Methotrexate—ankylosing spondylitis	0.006	0.012	CcSEcCtD
Fulvestrant—Inflammation—Methylprednisolone—ankylosing spondylitis	0.00569	0.0114	CcSEcCtD
Fulvestrant—Injury—Prednisolone—ankylosing spondylitis	0.00475	0.00948	CcSEcCtD
Fulvestrant—Injury—Triamcinolone—ankylosing spondylitis	0.00437	0.00872	CcSEcCtD
Fulvestrant—Injury—Methylprednisolone—ankylosing spondylitis	0.00436	0.0087	CcSEcCtD
Fulvestrant—Injury—Betamethasone—ankylosing spondylitis	0.00396	0.00791	CcSEcCtD
Fulvestrant—Injury—Dexamethasone—ankylosing spondylitis	0.00396	0.00791	CcSEcCtD
Fulvestrant—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.00386	0.00771	CcSEcCtD
Fulvestrant—Inflammation—Methotrexate—ankylosing spondylitis	0.00377	0.00752	CcSEcCtD
Fulvestrant—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.00362	0.00723	CcSEcCtD
Fulvestrant—Influenza—Triamcinolone—ankylosing spondylitis	0.00347	0.00693	CcSEcCtD
Fulvestrant—Injury—Prednisone—ankylosing spondylitis	0.00345	0.00689	CcSEcCtD
Fulvestrant—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00309	0.00616	CcSEcCtD
Fulvestrant—Infestation—Methylprednisolone—ankylosing spondylitis	0.00309	0.00616	CcSEcCtD
Fulvestrant—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00304	0.00606	CcSEcCtD
Fulvestrant—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00302	0.00603	CcSEcCtD
Fulvestrant—Sweating—Methylprednisolone—ankylosing spondylitis	0.00296	0.00591	CcSEcCtD
Fulvestrant—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00295	0.00589	CcSEcCtD
Fulvestrant—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00279	0.00557	CcSEcCtD
Fulvestrant—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00279	0.00556	CcSEcCtD
Fulvestrant—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00278	0.00555	CcSEcCtD
Fulvestrant—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00277	0.00553	CcSEcCtD
Fulvestrant—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00276	0.0055	CcSEcCtD
Fulvestrant—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00272	0.00544	CcSEcCtD
Fulvestrant—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00253	0.00506	CcSEcCtD
Fulvestrant—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00253	0.00506	CcSEcCtD
Fulvestrant—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00252	0.00503	CcSEcCtD
Fulvestrant—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00252	0.00503	CcSEcCtD
Fulvestrant—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00251	0.00502	CcSEcCtD
Fulvestrant—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.0025	0.005	CcSEcCtD
Fulvestrant—Depression—Prednisone—ankylosing spondylitis	0.00244	0.00487	CcSEcCtD
Fulvestrant—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00241	0.00482	CcSEcCtD
Fulvestrant—Angioedema—Prednisolone—ankylosing spondylitis	0.0024	0.0048	CcSEcCtD
Fulvestrant—Breast disorder—Methotrexate—ankylosing spondylitis	0.0024	0.00478	CcSEcCtD
Fulvestrant—Vertigo—Prednisolone—ankylosing spondylitis	0.00236	0.00472	CcSEcCtD
Fulvestrant—Back pain—Triamcinolone—ankylosing spondylitis	0.00234	0.00467	CcSEcCtD
Fulvestrant—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00229	0.00457	CcSEcCtD
Fulvestrant—Angiopathy—Betamethasone—ankylosing spondylitis	0.00229	0.00457	CcSEcCtD
Fulvestrant—Angioedema—Triamcinolone—ankylosing spondylitis	0.00221	0.00441	CcSEcCtD
Fulvestrant—Haemoglobin—Prednisone—ankylosing spondylitis	0.00221	0.0044	CcSEcCtD
Fulvestrant—Angioedema—Methylprednisolone—ankylosing spondylitis	0.0022	0.0044	CcSEcCtD
Fulvestrant—Haemorrhage—Prednisone—ankylosing spondylitis	0.00219	0.00438	CcSEcCtD
Fulvestrant—Vertigo—Triamcinolone—ankylosing spondylitis	0.00217	0.00434	CcSEcCtD
Fulvestrant—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00217	0.00433	CcSEcCtD
Fulvestrant—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00216	0.00431	CcSEcCtD
Fulvestrant—Cough—Triamcinolone—ankylosing spondylitis	0.00211	0.00421	CcSEcCtD
Fulvestrant—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00207	0.00414	CcSEcCtD
Fulvestrant—Myalgia—Triamcinolone—ankylosing spondylitis	0.00206	0.00411	CcSEcCtD
Fulvestrant—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00205	0.0041	CcSEcCtD
Fulvestrant—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00205	0.0041	CcSEcCtD
Fulvestrant—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00205	0.00409	CcSEcCtD
Fulvestrant—Infestation—Methotrexate—ankylosing spondylitis	0.00204	0.00408	CcSEcCtD
Fulvestrant—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00204	0.00408	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00204	0.00407	CcSEcCtD
Fulvestrant—Depression—Methotrexate—ankylosing spondylitis	0.00204	0.00407	CcSEcCtD
Fulvestrant—Angioedema—Betamethasone—ankylosing spondylitis	0.002	0.004	CcSEcCtD
Fulvestrant—Angioedema—Dexamethasone—ankylosing spondylitis	0.002	0.004	CcSEcCtD
Fulvestrant—Angiopathy—Prednisone—ankylosing spondylitis	0.00199	0.00398	CcSEcCtD
Fulvestrant—Immune system disorder—Prednisone—ankylosing spondylitis	0.00198	0.00396	CcSEcCtD
Fulvestrant—Vertigo—Dexamethasone—ankylosing spondylitis	0.00197	0.00394	CcSEcCtD
Fulvestrant—Vertigo—Betamethasone—ankylosing spondylitis	0.00197	0.00394	CcSEcCtD
Fulvestrant—Infection—Triamcinolone—ankylosing spondylitis	0.00196	0.00391	CcSEcCtD
Fulvestrant—Sweating—Methotrexate—ankylosing spondylitis	0.00196	0.00391	CcSEcCtD
Fulvestrant—Infection—Methylprednisolone—ankylosing spondylitis	0.00196	0.00391	CcSEcCtD
Fulvestrant—Insomnia—Prednisolone—ankylosing spondylitis	0.00194	0.00388	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00193	0.00386	CcSEcCtD
Fulvestrant—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00193	0.00386	CcSEcCtD
Fulvestrant—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00193	0.00385	CcSEcCtD
Fulvestrant—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00191	0.00382	CcSEcCtD
Fulvestrant—Malnutrition—Prednisone—ankylosing spondylitis	0.00191	0.00381	CcSEcCtD
Fulvestrant—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00191	0.00381	CcSEcCtD
Fulvestrant—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.0019	0.0038	CcSEcCtD
Fulvestrant—Myalgia—Dexamethasone—ankylosing spondylitis	0.00187	0.00373	CcSEcCtD
Fulvestrant—Myalgia—Betamethasone—ankylosing spondylitis	0.00187	0.00373	CcSEcCtD
Fulvestrant—Anxiety—Dexamethasone—ankylosing spondylitis	0.00186	0.00372	CcSEcCtD
Fulvestrant—Anxiety—Betamethasone—ankylosing spondylitis	0.00186	0.00372	CcSEcCtD
Fulvestrant—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00184	0.00368	CcSEcCtD
Fulvestrant—Pain—Prednisolone—ankylosing spondylitis	0.00183	0.00366	CcSEcCtD
Fulvestrant—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00183	0.00366	CcSEcCtD
Fulvestrant—Hepatitis—Methotrexate—ankylosing spondylitis	0.00183	0.00366	CcSEcCtD
Fulvestrant—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00182	0.00363	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.0018	0.00359	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00179	0.00358	CcSEcCtD
Fulvestrant—Insomnia—Triamcinolone—ankylosing spondylitis	0.00178	0.00356	CcSEcCtD
Fulvestrant—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00178	0.00356	CcSEcCtD
Fulvestrant—Infection—Dexamethasone—ankylosing spondylitis	0.00178	0.00355	CcSEcCtD
Fulvestrant—Infection—Betamethasone—ankylosing spondylitis	0.00178	0.00355	CcSEcCtD
Fulvestrant—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00177	0.00354	CcSEcCtD
Fulvestrant—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00177	0.00353	CcSEcCtD
Fulvestrant—Anaemia—Prednisone—ankylosing spondylitis	0.00177	0.00353	CcSEcCtD
Fulvestrant—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00176	0.00351	CcSEcCtD
Fulvestrant—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00176	0.00351	CcSEcCtD
Fulvestrant—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00176	0.00351	CcSEcCtD
Fulvestrant—Angioedema—Prednisone—ankylosing spondylitis	0.00175	0.00349	CcSEcCtD
Fulvestrant—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00174	0.00347	CcSEcCtD
Fulvestrant—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00173	0.00346	CcSEcCtD
Fulvestrant—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00173	0.00346	CcSEcCtD
Fulvestrant—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00173	0.00346	CcSEcCtD
Fulvestrant—Vertigo—Prednisone—ankylosing spondylitis	0.00172	0.00343	CcSEcCtD
Fulvestrant—Anorexia—Dexamethasone—ankylosing spondylitis	0.00171	0.00341	CcSEcCtD
Fulvestrant—Anorexia—Betamethasone—ankylosing spondylitis	0.00171	0.00341	CcSEcCtD
Fulvestrant—Urticaria—Prednisolone—ankylosing spondylitis	0.0017	0.0034	CcSEcCtD
Fulvestrant—Fatigue—Triamcinolone—ankylosing spondylitis	0.0017	0.0034	CcSEcCtD
Fulvestrant—Fatigue—Methylprednisolone—ankylosing spondylitis	0.0017	0.00339	CcSEcCtD
Fulvestrant—Pain—Triamcinolone—ankylosing spondylitis	0.00169	0.00337	CcSEcCtD
Fulvestrant—Angiopathy—Methotrexate—ankylosing spondylitis	0.00166	0.00332	CcSEcCtD
Fulvestrant—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00166	0.00331	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00163	0.00326	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00163	0.00326	CcSEcCtD
Fulvestrant—Myalgia—Prednisone—ankylosing spondylitis	0.00163	0.00325	CcSEcCtD
Fulvestrant—Arthralgia—Prednisone—ankylosing spondylitis	0.00163	0.00325	CcSEcCtD
Fulvestrant—Anxiety—Prednisone—ankylosing spondylitis	0.00162	0.00324	CcSEcCtD
Fulvestrant—Insomnia—Betamethasone—ankylosing spondylitis	0.00162	0.00323	CcSEcCtD
Fulvestrant—Insomnia—Dexamethasone—ankylosing spondylitis	0.00162	0.00323	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00162	0.00323	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00161	0.00321	CcSEcCtD
Fulvestrant—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00161	0.00321	CcSEcCtD
Fulvestrant—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00161	0.00321	CcSEcCtD
Fulvestrant—Malnutrition—Methotrexate—ankylosing spondylitis	0.0016	0.00319	CcSEcCtD
Fulvestrant—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00158	0.00316	CcSEcCtD
Fulvestrant—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00158	0.00315	CcSEcCtD
Fulvestrant—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00158	0.00315	CcSEcCtD
Fulvestrant—Urticaria—Triamcinolone—ankylosing spondylitis	0.00157	0.00313	CcSEcCtD
Fulvestrant—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00156	0.00312	CcSEcCtD
Fulvestrant—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00156	0.00311	CcSEcCtD
Fulvestrant—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00156	0.00311	CcSEcCtD
Fulvestrant—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00156	0.00311	CcSEcCtD
Fulvestrant—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00156	0.00311	CcSEcCtD
Fulvestrant—Infection—Prednisone—ankylosing spondylitis	0.00155	0.00309	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00155	0.00309	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00155	0.00309	CcSEcCtD
Fulvestrant—Back pain—Methotrexate—ankylosing spondylitis	0.00154	0.00308	CcSEcCtD
Fulvestrant—Fatigue—Dexamethasone—ankylosing spondylitis	0.00154	0.00308	CcSEcCtD
Fulvestrant—Fatigue—Betamethasone—ankylosing spondylitis	0.00154	0.00308	CcSEcCtD
Fulvestrant—Pain—Betamethasone—ankylosing spondylitis	0.00153	0.00306	CcSEcCtD
Fulvestrant—Pain—Dexamethasone—ankylosing spondylitis	0.00153	0.00306	CcSEcCtD
Fulvestrant—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00153	0.00305	CcSEcCtD
Fulvestrant—Skin disorder—Prednisone—ankylosing spondylitis	0.00151	0.00302	CcSEcCtD
Fulvestrant—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00151	0.00301	CcSEcCtD
Fulvestrant—Anorexia—Prednisone—ankylosing spondylitis	0.00149	0.00297	CcSEcCtD
Fulvestrant—Anaemia—Methotrexate—ankylosing spondylitis	0.00148	0.00295	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00146	0.00292	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00146	0.00292	CcSEcCtD
Fulvestrant—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00145	0.0029	CcSEcCtD
Fulvestrant—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00145	0.0029	CcSEcCtD
Fulvestrant—Vertigo—Methotrexate—ankylosing spondylitis	0.00143	0.00286	CcSEcCtD
Fulvestrant—Leukopenia—Methotrexate—ankylosing spondylitis	0.00143	0.00285	CcSEcCtD
Fulvestrant—Urticaria—Dexamethasone—ankylosing spondylitis	0.00142	0.00284	CcSEcCtD
Fulvestrant—Urticaria—Betamethasone—ankylosing spondylitis	0.00142	0.00284	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00142	0.00284	CcSEcCtD
Fulvestrant—Dizziness—Prednisolone—ankylosing spondylitis	0.00142	0.00283	CcSEcCtD
Fulvestrant—Asthenia—Triamcinolone—ankylosing spondylitis	0.00142	0.00283	CcSEcCtD
Fulvestrant—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00142	0.00283	CcSEcCtD
Fulvestrant—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00142	0.00283	CcSEcCtD
Fulvestrant—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00142	0.00283	CcSEcCtD
Fulvestrant—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00142	0.00283	CcSEcCtD
Fulvestrant—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00141	0.00282	CcSEcCtD
Fulvestrant—Insomnia—Prednisone—ankylosing spondylitis	0.00141	0.00282	CcSEcCtD
Fulvestrant—Paraesthesia—Prednisone—ankylosing spondylitis	0.0014	0.0028	CcSEcCtD
Fulvestrant—Pruritus—Triamcinolone—ankylosing spondylitis	0.0014	0.00279	CcSEcCtD
Fulvestrant—Cough—Methotrexate—ankylosing spondylitis	0.00139	0.00278	CcSEcCtD
Fulvestrant—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00139	0.00278	CcSEcCtD
Fulvestrant—Dyspepsia—Prednisone—ankylosing spondylitis	0.00137	0.00274	CcSEcCtD
Fulvestrant—Arthralgia—Methotrexate—ankylosing spondylitis	0.00136	0.00271	CcSEcCtD
Fulvestrant—Myalgia—Methotrexate—ankylosing spondylitis	0.00136	0.00271	CcSEcCtD
Fulvestrant—Chest pain—Methotrexate—ankylosing spondylitis	0.00136	0.00271	CcSEcCtD
Fulvestrant—Decreased appetite—Prednisone—ankylosing spondylitis	0.00136	0.00271	CcSEcCtD
Fulvestrant—Rash—Prednisolone—ankylosing spondylitis	0.00135	0.0027	CcSEcCtD
Fulvestrant—Dermatitis—Prednisolone—ankylosing spondylitis	0.00135	0.0027	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00135	0.0027	CcSEcCtD
Fulvestrant—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00135	0.00269	CcSEcCtD
Fulvestrant—Fatigue—Prednisone—ankylosing spondylitis	0.00134	0.00268	CcSEcCtD
Fulvestrant—Headache—Prednisolone—ankylosing spondylitis	0.00134	0.00268	CcSEcCtD
Fulvestrant—Constipation—Prednisone—ankylosing spondylitis	0.00133	0.00266	CcSEcCtD
Fulvestrant—Dizziness—Triamcinolone—ankylosing spondylitis	0.0013	0.00261	CcSEcCtD
Fulvestrant—Dizziness—Methylprednisolone—ankylosing spondylitis	0.0013	0.0026	CcSEcCtD
Fulvestrant—Infection—Methotrexate—ankylosing spondylitis	0.00129	0.00258	CcSEcCtD
Fulvestrant—Asthenia—Betamethasone—ankylosing spondylitis	0.00128	0.00256	CcSEcCtD
Fulvestrant—Asthenia—Dexamethasone—ankylosing spondylitis	0.00128	0.00256	CcSEcCtD
Fulvestrant—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00128	0.00255	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00128	0.00255	CcSEcCtD
Fulvestrant—Nausea—Prednisolone—ankylosing spondylitis	0.00127	0.00254	CcSEcCtD
Fulvestrant—Pruritus—Dexamethasone—ankylosing spondylitis	0.00127	0.00253	CcSEcCtD
Fulvestrant—Pruritus—Betamethasone—ankylosing spondylitis	0.00127	0.00253	CcSEcCtD
Fulvestrant—Skin disorder—Methotrexate—ankylosing spondylitis	0.00127	0.00253	CcSEcCtD
Fulvestrant—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00126	0.00252	CcSEcCtD
Fulvestrant—Vomiting—Triamcinolone—ankylosing spondylitis	0.00125	0.00251	CcSEcCtD
Fulvestrant—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00125	0.0025	CcSEcCtD
Fulvestrant—Rash—Triamcinolone—ankylosing spondylitis	0.00124	0.00248	CcSEcCtD
Fulvestrant—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00124	0.00248	CcSEcCtD
Fulvestrant—Anorexia—Methotrexate—ankylosing spondylitis	0.00124	0.00248	CcSEcCtD
Fulvestrant—Rash—Methylprednisolone—ankylosing spondylitis	0.00124	0.00248	CcSEcCtD
Fulvestrant—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00124	0.00248	CcSEcCtD
Fulvestrant—Urticaria—Prednisone—ankylosing spondylitis	0.00124	0.00247	CcSEcCtD
Fulvestrant—Headache—Triamcinolone—ankylosing spondylitis	0.00124	0.00247	CcSEcCtD
Fulvestrant—Headache—Methylprednisolone—ankylosing spondylitis	0.00123	0.00246	CcSEcCtD
Fulvestrant—Body temperature increased—Prednisone—ankylosing spondylitis	0.00123	0.00246	CcSEcCtD
Fulvestrant—Abdominal pain—Prednisone—ankylosing spondylitis	0.00123	0.00246	CcSEcCtD
Fulvestrant—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00123	0.00245	CcSEcCtD
Fulvestrant—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00123	0.00245	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00119	0.00237	CcSEcCtD
Fulvestrant—Dizziness—Betamethasone—ankylosing spondylitis	0.00118	0.00236	CcSEcCtD
Fulvestrant—Dizziness—Dexamethasone—ankylosing spondylitis	0.00118	0.00236	CcSEcCtD
Fulvestrant—Insomnia—Methotrexate—ankylosing spondylitis	0.00118	0.00235	CcSEcCtD
Fulvestrant—Nausea—Triamcinolone—ankylosing spondylitis	0.00117	0.00234	CcSEcCtD
Fulvestrant—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00117	0.00234	CcSEcCtD
Fulvestrant—Nausea—Methylprednisolone—ankylosing spondylitis	0.00117	0.00234	CcSEcCtD
Fulvestrant—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00116	0.00232	CcSEcCtD
Fulvestrant—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00115	0.00229	CcSEcCtD
Fulvestrant—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00115	0.00229	CcSEcCtD
Fulvestrant—Vomiting—Betamethasone—ankylosing spondylitis	0.00114	0.00227	CcSEcCtD
Fulvestrant—Vomiting—Dexamethasone—ankylosing spondylitis	0.00114	0.00227	CcSEcCtD
Fulvestrant—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00113	0.00226	CcSEcCtD
Fulvestrant—Rash—Betamethasone—ankylosing spondylitis	0.00113	0.00225	CcSEcCtD
Fulvestrant—Rash—Dexamethasone—ankylosing spondylitis	0.00113	0.00225	CcSEcCtD
Fulvestrant—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00113	0.00225	CcSEcCtD
Fulvestrant—Dermatitis—Betamethasone—ankylosing spondylitis	0.00113	0.00225	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00113	0.00225	CcSEcCtD
Fulvestrant—Fatigue—Methotrexate—ankylosing spondylitis	0.00112	0.00224	CcSEcCtD
Fulvestrant—Headache—Dexamethasone—ankylosing spondylitis	0.00112	0.00224	CcSEcCtD
Fulvestrant—Headache—Betamethasone—ankylosing spondylitis	0.00112	0.00224	CcSEcCtD
Fulvestrant—Asthenia—Prednisone—ankylosing spondylitis	0.00112	0.00223	CcSEcCtD
Fulvestrant—Pain—Methotrexate—ankylosing spondylitis	0.00111	0.00222	CcSEcCtD
Fulvestrant—Pruritus—Prednisone—ankylosing spondylitis	0.0011	0.0022	CcSEcCtD
Fulvestrant—Diarrhoea—Prednisone—ankylosing spondylitis	0.00107	0.00213	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00107	0.00213	CcSEcCtD
Fulvestrant—Nausea—Betamethasone—ankylosing spondylitis	0.00106	0.00212	CcSEcCtD
Fulvestrant—Nausea—Dexamethasone—ankylosing spondylitis	0.00106	0.00212	CcSEcCtD
Fulvestrant—Urticaria—Methotrexate—ankylosing spondylitis	0.00104	0.00207	CcSEcCtD
Fulvestrant—Dizziness—Prednisone—ankylosing spondylitis	0.00103	0.00206	CcSEcCtD
Fulvestrant—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00103	0.00206	CcSEcCtD
Fulvestrant—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00103	0.00206	CcSEcCtD
Fulvestrant—Vomiting—Prednisone—ankylosing spondylitis	0.000991	0.00198	CcSEcCtD
Fulvestrant—Rash—Prednisone—ankylosing spondylitis	0.000983	0.00196	CcSEcCtD
Fulvestrant—Dermatitis—Prednisone—ankylosing spondylitis	0.000982	0.00196	CcSEcCtD
Fulvestrant—Headache—Prednisone—ankylosing spondylitis	0.000977	0.00195	CcSEcCtD
Fulvestrant—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00096	0.00192	CcSEcCtD
Fulvestrant—Asthenia—Methotrexate—ankylosing spondylitis	0.000935	0.00187	CcSEcCtD
Fulvestrant—Nausea—Prednisone—ankylosing spondylitis	0.000926	0.00185	CcSEcCtD
Fulvestrant—Pruritus—Methotrexate—ankylosing spondylitis	0.000922	0.00184	CcSEcCtD
Fulvestrant—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000892	0.00178	CcSEcCtD
Fulvestrant—Dizziness—Methotrexate—ankylosing spondylitis	0.000862	0.00172	CcSEcCtD
Fulvestrant—Vomiting—Methotrexate—ankylosing spondylitis	0.000829	0.00165	CcSEcCtD
Fulvestrant—Rash—Methotrexate—ankylosing spondylitis	0.000822	0.00164	CcSEcCtD
Fulvestrant—Dermatitis—Methotrexate—ankylosing spondylitis	0.000821	0.00164	CcSEcCtD
Fulvestrant—Headache—Methotrexate—ankylosing spondylitis	0.000816	0.00163	CcSEcCtD
Fulvestrant—Nausea—Methotrexate—ankylosing spondylitis	0.000774	0.00155	CcSEcCtD
